Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 139.35B | 145.59B | 153.22B | 150.02B | 133.89B | 154.31B |
Gross Profit | 25.65B | 28.58B | 34.38B | 34.02B | 30.68B | 25.59B |
EBITDA | 17.41B | 21.50B | 27.44B | 27.25B | 23.22B | 15.39B |
Net Income | 6.81B | 10.21B | 14.26B | 14.50B | 11.05B | 3.63B |
Balance Sheet | ||||||
Total Assets | 256.63B | 265.01B | 263.02B | 260.01B | 259.83B | 285.74B |
Cash, Cash Equivalents and Short-Term Investments | 26.87B | 21.74B | 18.99B | 24.36B | 29.86B | 28.45B |
Total Debt | 86.40B | 93.04B | 87.21B | 84.41B | 93.85B | 114.76B |
Total Liabilities | 164.91B | 171.38B | 170.21B | 173.47B | 186.66B | 223.49B |
Stockholders Equity | 90.83B | 92.63B | 91.77B | 85.42B | 71.95B | 60.69B |
Cash Flow | ||||||
Free Cash Flow | 12.19B | 9.07B | 6.26B | 9.99B | 17.23B | 13.77B |
Operating Cash Flow | 20.87B | 17.73B | 14.47B | 16.89B | 24.55B | 22.33B |
Investing Cash Flow | -11.10B | -8.75B | -7.32B | -3.45B | -6.23B | -6.42B |
Financing Cash Flow | -8.33B | -10.75B | -8.39B | -19.03B | -19.06B | -10.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $55.47B | 7.64 | 7.24% | 8.40% | -6.62% | -43.51% | |
77 Outperform | $995.76B | 178.78 | 8.43% | ― | -2.73% | -51.64% | |
77 Outperform | $237.02B | 7.70 | 13.36% | 3.01% | 1.06% | -7.05% | |
72 Outperform | $50.06B | 8.37 | 7.07% | 0.97% | 5.34% | -28.29% | |
71 Outperform | $44.02B | 13.97 | 7.11% | 6.93% | 2.72% | -17.58% | |
71 Outperform | $50.61B | 8.98 | 5.17% | 4.33% | 0.83% | -26.70% | |
61 Neutral | $16.54B | 10.12 | -9.01% | 3.34% | 1.45% | -22.43% |